ClinVar Genomic variation as it relates to human health
NM_015474.4(SAMHD1):c.428G>A (p.Arg143His)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_015474.4(SAMHD1):c.428G>A (p.Arg143His)
Variation ID: 126411 Accession: VCV000126411.15
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 20q11.23 20: 36935110 (GRCh38) [ NCBI UCSC ] 20: 35563513 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Mar 24, 2015 Sep 16, 2024 Jan 31, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_015474.4:c.428G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_056289.2:p.Arg143His missense NM_001363729.2:c.428G>A NP_001350658.1:p.Arg143His missense NM_001363733.2:c.428G>A NP_001350662.1:p.Arg143His missense NC_000020.11:g.36935110C>T NC_000020.10:g.35563513C>T NG_017059.1:g.21734G>A LRG_281:g.21734G>A LRG_281t1:c.428G>A LRG_281p1:p.Arg143His Q9Y3Z3:p.Arg143His - Protein change
- R143H
- Other names
- -
- Canonical SPDI
- NC_000020.11:36935109:C:T
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD) 0.00001
The Genome Aggregation Database (gnomAD), exomes 0.00001
Trans-Omics for Precision Medicine (TOPMed) 0.00003
NHLBI Exome Sequencing Project (ESP) Exome Variant Server 0.00008
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
SAMHD1 | - | - |
GRCh38 GRCh37 |
824 | 905 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
Jan 31, 2024 | RCV000114352.22 | |
Pathogenic/Likely pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Dec 19, 2023 | RCV002223787.10 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(Dec 19, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV005201559.1
First in ClinVar: Sep 16, 2024 Last updated: Sep 16, 2024 |
Comment:
Published functional studies demonstrate that this variant has a damaging effect and leads to a loss of protein function (PMID: 28229507); This variant is associated … (more)
Published functional studies demonstrate that this variant has a damaging effect and leads to a loss of protein function (PMID: 28229507); This variant is associated with the following publications: (PMID: 19525956, 30487145, 23364794, 22056990, 22149989, 34055681, 33683010, 27943079, 29379009, 28229507, 32371413) (less)
|
|
Pathogenic
(Sep 25, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Aicardi-Goutieres syndrome 5
Affected status: yes
Allele origin:
germline
|
Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital
Accession: SCV001423609.1
First in ClinVar: Jul 27, 2020 Last updated: Jul 27, 2020 |
Comment:
[ACMG/AMP: PS3, PM2, PM5, PP3, PP5] This alteration is supported by well-established in vitro or in vivo functional studies to have a damaging effect on … (more)
[ACMG/AMP: PS3, PM2, PM5, PP3, PP5] This alteration is supported by well-established in vitro or in vivo functional studies to have a damaging effect on protein function or splicing [PS3], is absent from or rarely observed in large-scale population databases [PM2], is a novel missense change at an amino residue where a different missense change has been deemed to be pathogenic [PM5], is predicted to be damaging by multiple functional prediction tools [PP3], was reported as a pathogenic/likely pathogenic alteration by a reputable source (ClinVar or other correspondence from a clinical testing laboratory) [PP5]. (less)
|
|
Likely pathogenic
(Mar 22, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Not provided
Affected status: yes
Allele origin:
germline
|
AiLife Diagnostics, AiLife Diagnostics
Accession: SCV002502603.1
First in ClinVar: Apr 23, 2022 Last updated: Apr 23, 2022 |
Number of individuals with the variant: 1
Secondary finding: no
|
|
Pathogenic
(Jan 31, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Aicardi-Goutieres syndrome 5
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV001373235.4
First in ClinVar: Jul 16, 2020 Last updated: Feb 14, 2024 |
Comment:
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 143 of the SAMHD1 protein (p.Arg143His). … (more)
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 143 of the SAMHD1 protein (p.Arg143His). This variant is present in population databases (rs369035155, gnomAD 0.004%). This missense change has been observed in individuals with Aicardi-Goutières syndrome (PMID: 19525956, 33683010; Invitae). ClinVar contains an entry for this variant (Variation ID: 126411). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SAMHD1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects SAMHD1 function (PMID: 28229507, 29379009). This variant disrupts the p.Arg143 amino acid residue in SAMHD1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19525956, 26431200, 28229507). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. (less)
|
|
not provided
(-)
|
no classification provided
Method: literature only
|
Aicardi-Goutieres syndrome 5
Affected status: yes
Allele origin:
germline
|
GeneReviews
Accession: SCV000147931.3
First in ClinVar: Apr 19, 2014 Last updated: Oct 01, 2022 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Aicardi-Goutières syndrome may present with positive newborn screen for X-linked adrenoleukodystrophy. | Tise CG | American journal of medical genetics. Part A | 2021 | PMID: 33683010 |
Disease-associated mosaic variation in clinical exome sequencing: a two-year pediatric tertiary care experience. | Miller CR | Cold Spring Harbor molecular case studies | 2020 | PMID: 32371413 |
High-frequency actionable pathogenic exome variants in an average-risk cohort. | Rego S | Cold Spring Harbor molecular case studies | 2018 | PMID: 30487145 |
The SAM domain of mouse SAMHD1 is critical for its activation and regulation. | Buzovetsky O | Nature communications | 2018 | PMID: 29379009 |
A SAMHD1 mutation associated with Aicardi-Goutières syndrome uncouples the ability of SAMHD1 to restrict HIV-1 from its ability to downmodulate type I interferon in humans. | White TE | Human mutation | 2017 | PMID: 28229507 |
Aicardi-Goutières Syndrome. | Adam MP | - | 2016 | PMID: 20301648 |
Phospho-dependent Regulation of SAMHD1 Oligomerisation Couples Catalysis and Restriction. | Arnold LH | PLoS pathogens | 2015 | PMID: 26431200 |
Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. | Rice GI | Nature genetics | 2009 | PMID: 19525956 |
Text-mined citations for rs369035155 ...
HelpRecord last updated Nov 25, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.